Product Information

TRIAMTERENE-HYDROCHLOROTHIAZIDE 75-50 MG TAB is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.1254 per EA under NDC 68382085701. Its NADAC has been published 365 times since Aug 28, 2019.

FDA first approved this application on Jun 29, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TRIAMTERENE-HYDROCHLOROTHIAZIDE 75-50 MG TAB

triamterene and hydrochlorothiazide
$0.1254per EA

Strength

50; 75 mg/1; mg/1

NDC

68382085701

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA208360

FDA Approved

6/29/2018

TE Code

AB

On Market Since

9/4/2018

Pharmacological Classes

Decreased Renal K+ Excretion
Increased Diuresis
Increased Diuresis
Potassium-sparing Diuretic
Thiazide Diuretic
Thiazides

Price Statistics

The NADAC for TRIAMTERENE-HYDROCHLOROTHIAZIDE 75-50 MG TAB has been published 365 times since Aug 28, 2019, and over the history we have for it it has declined 12.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1254 per EA
All-time high$0.1490 (Oct 16, 2019)
All-time low$0.0859 (Nov 20, 2024)
52-week high$0.1254
52-week low$0.1115
Median price$0.1236
Average price$0.1227
Largest weekly change-25.0% (Nov 20, 2024)
Weeks tracked365
Tracking sinceAug 28, 2019

Price History

1W

+7.3%

1M

+7.3%

3M

+9.8%

6M

+11.7%

1Y

+9.1%

3Y

+7.9%

5Y

-8.7%

All

-12.6%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of TRIAMTERENE-HYDROCHLOROTHIAZIDE 75-50 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for TRIAMTERENE-HYDROCHLOROTHIAZIDE 75-50 MG TAB, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.1254 per EA (NDC 68382085701), effective Aug 19, 2026.

How has the price of TRIAMTERENE-HYDROCHLOROTHIAZIDE 75-50 MG TAB changed over time?

Over the history we have for it, the NADAC for TRIAMTERENE-HYDROCHLOROTHIAZIDE 75-50 MG TAB has declined 12.6%. It has been tracked across 365 weekly CMS publications since Aug 28, 2019.

What are the highest and lowest recorded NADAC prices for TRIAMTERENE-HYDROCHLOROTHIAZIDE 75-50 MG TAB?

Since Aug 28, 2019, the NADAC for TRIAMTERENE-HYDROCHLOROTHIAZIDE 75-50 MG TAB has ranged from a low of $0.0859 (Nov 20, 2024) to a high of $0.1490 (Oct 16, 2019), with a median of $0.1236 per EA.

Are there cheaper alternatives to TRIAMTERENE-HYDROCHLOROTHIAZIDE 75-50 MG TAB?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as TRIAMTERENE-HYDROCHLOROTHIAZIDE 75-50 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures TRIAMTERENE-HYDROCHLOROTHIAZIDE 75-50 MG TAB?

TRIAMTERENE-HYDROCHLOROTHIAZIDE 75-50 MG TAB (NDC 68382085701) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.